XML 320 R20.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Shareholders' Equity
12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Shareholders' Equity Note 12—Shareholders' Equity
Share Data: A summary of common share activity is presented in the following chart.
Common Stock
IssuedTreasury
Stock
2017:
Balance at January 1, 2017127,218,183  (9,187,075) 
Grants of restricted stock—  9,135  
Vesting of performance shares—  119,896  
Issuance of common stock due to exercise of stock options—  1,661,808  
Treasury stock acquired—  (5,228,868) 
Retirement of treasury stock(3,000,000) 3,000,000  
Balance at December 31, 2017
124,218,183  (9,625,104) 
2018:
Grants of restricted stock—  10,805  
Forfeitures of restricted stock—  (7,500) 
Vesting of performance shares—  149,898  
Issuance of common stock due to exercise of stock options—  897,622  
Treasury stock acquired—  (4,950,868) 
Retirement of treasury stock(3,000,000) 3,000,000  
Balance at December 31, 2018
121,218,183  (10,525,147) 
2019:
Grants of restricted stock—  8,840  
Vesting of performance shares—  311,399  
Issuance of common stock due to exercise of stock options—  1,810,559  
Treasury stock acquired—  (5,103,591) 
Retirement of treasury stock(4,000,000) 4,000,000  
Balance at December 31, 2019
117,218,183  (9,497,940) 

There was no activity related to the preferred stock in years 2017 through 2019.
Acquisition of Common Shares: Globe Life shares are acquired from time to time through open market purchases under the Globe Life stock repurchase program when it is determined to be the best use of Globe Life's excess cash flows. We deem that it yields a return that is better than available alternatives and exceeds our cost of equity. When stock options are exercised, proceeds from the exercises are generally used to repurchase approximately the number of shares available with those funds in order to reduce dilution. See the following summary below:
Globe Life Share Repurchase ProgramShare Repurchase for Dilution Purposes
Shares Acquired
(in thousands)
Total CostAverage PriceShares Acquired
(in thousands)
Total CostAverage Price
2019
3,932  $350,080  $89.04  1,209  $109,489  $90.52  
2018
4,406  371,794  84.38  571  49,955  87.54  
2017
4,126  324,622  78.67  1,103  88,367  80.15  
Restrictions: Restrictions exist on the flow of funds to Globe Life Inc. from its insurance subsidiaries. Statutory regulations require life insurance subsidiaries to maintain certain minimum amounts of capital and surplus. Dividends from insurance subsidiaries of Globe Life Inc. are restricted based on regulations by their states of domicile. Additionally, insurance company distributions are generally not permitted in excess of statutory surplus. Subsidiaries are also subject to certain minimum capital requirements. Subsidiaries of Globe Life paid cash dividends to the Parent Company in the amount of $480 million in 2019, $448 million in 2018, and $454 million in 2017. As of December 31, 2019, dividends from insurance subsidiaries to the Parent Company available to be paid in 2020 are limited to the amount of $412 million without regulatory approval, such that $1.0 billion was considered restricted net assets of the subsidiaries. Dividends exceeding these limitations may be available during the year pending regulatory approval. While there are no legal restrictions on the payment of dividends to shareholders from Globe Life's retained earnings, retained earnings as of December 31, 2019 were restricted by lenders’ covenants which require the Company to maintain and not distribute $4.0 billion from its total consolidated retained earnings of $5.6 billion.
Earnings per Share: A reconciliation of basic and diluted weighted-average shares outstanding used in the computation of basic and diluted earnings per share is as follows:
Year Ended December 31,
201920182017
Basic weighted average shares outstanding109,213,524  112,872,581  116,342,529  
Weighted average dilutive options outstanding2,167,726  2,376,372  2,640,965  
Diluted weighted average shares outstanding111,381,250  115,248,953  118,983,494  
Antidilutive shares21,556  1,161,521  —  
Antidilutive shares are excluded from the calculation of diluted earnings per share.